Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Resources
Interactive Tools
Sponsored
Biomarker Consortium
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Stephen Liu, MD, MedStar Georgetown University Hospital
home
Articles
NSCLC Management: Second-Line Options
July 16th 2020
Squamous Cell Frontline Therapy: IMpower 131, KEYNOTE-407
July 16th 2020
CheckMate 817 Overview
July 16th 2020
PD-L1 Combination Therapy Clinical Trials
July 16th 2020
Frontline PD-L1 Monotherapy: KEYNOTE-042 and IMpower110
July 16th 2020
CheckMate-9LA: Histology and Frontline Impact
July 16th 2020
Recent Combination Approval: CheckMate-9LA Regimen
July 16th 2020
CheckMate-227 Regimen Safety Profile
July 16th 2020
ASCO 2020 Data Update: CheckMate 227
July 16th 2020
Nondriver Adenocarcinoma: Determining Therapy
July 16th 2020
Review of Treatment for Limited-Stage Small-Cell Lung Cancer
July 6th 2020
Second- and Third-Line Treatment for ES-SCLC
July 6th 2020
Role of PCI Versus Brain MRI Surveillance in ES-SCLC
July 6th 2020
Expert Approaches to Treating Extensive Stage SCLC
July 6th 2020
KEYNOTE-604 and ECOG-ACRIN 5161 Trials for ES-SCLC
July 6th 2020
IMpower133 and CASPIAN Trials for Extensive Stage SCLC
July 6th 2020